GeneDx Holdings (WGSWW) Other Accumulated Expenses (2020 - 2025)
GeneDx Holdings has reported Other Accumulated Expenses over the past 6 years, most recently at $46.9 million for Q4 2025.
- Quarterly results put Other Accumulated Expenses at $46.9 million for Q4 2025, up 128.6% from a year ago — trailing twelve months through Dec 2025 was $46.9 million (up 128.6% YoY), and the annual figure for FY2025 was $46.9 million, up 128.6%.
- Other Accumulated Expenses for Q4 2025 was $46.9 million at GeneDx Holdings, up from $32.9 million in the prior quarter.
- Over the last five years, Other Accumulated Expenses for WGSWW hit a ceiling of $81.6 million in Q2 2022 and a floor of $1.0 million in Q2 2023.
- Median Other Accumulated Expenses over the past 5 years was $23.2 million (2021), compared with a mean of $24.7 million.
- Biggest five-year swings in Other Accumulated Expenses: crashed 98.77% in 2023 and later skyrocketed 2258.79% in 2025.
- GeneDx Holdings' Other Accumulated Expenses stood at $33.4 million in 2021, then plummeted by 89.24% to $3.6 million in 2022, then crashed by 61.62% to $1.4 million in 2023, then surged by 1386.44% to $20.5 million in 2024, then soared by 128.6% to $46.9 million in 2025.
- The last three reported values for Other Accumulated Expenses were $46.9 million (Q4 2025), $32.9 million (Q3 2025), and $19.1 million (Q2 2025) per Business Quant data.